Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vericel Corp Ord
VCELCurrent price
44.32 USD
-0.5 USD (-1.12%)
Last closed
44.72 USD
Company
vcel.com
ISIN
US92346J1088
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 249 015 296 USD
Yield for 12 month
+31.63 %
1Y
3Y
5Y
10Y
15Y
VCEL
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Address: 64 Sidney Street, Cambridge, MA, United States, 02139
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
57.25 USDP/E ratio
4587Dividend Yield
–Current Year
+197 516 000 USD
Last Year
+164 365 000 USD
Current Quarter
+52 662 000 USD
Last Quarter
+51 281 000 USD
Current Year
+135 576 000 USD
Last Year
+109 788 000 USD
Current Quarter
+36 601 000 USD
Last Quarter
+35 354 000 USD
Key Figures VCEL
1 year
3 years
5 years
10 years
EBITDA
1 183 000 USD
Operating Margin TTM
PE Ratio
4587
Return On Assets TTM
-0.7 %
PEG Ratio
–
Return On Equity TTM
0.36 %
Wall Street Target Price
57.25 USD
Revenue TTM
214 520 000 USD
Book Value
4.97 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
14.7 %
Dividend Yield
–
Gross Profit TTM
109 788 000 USD
Earnings per share
0.01 USD
Diluted Eps TTM
0.01 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
104.5 %
Profit Margin
0.37 %
Dividend Analytics VCEL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VCEL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:20
Payout Ratio
–
Last Split Date
16.10.2013
Dividend Date
–
Stock Valuation VCEL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
4587
Forward PE
75.188
Enterprise Value Revenue
10.4517
Price Sales TTM
10.4839
Enterprise Value EBITDA
310.5829
Price Book MRQ
9.2561
Financials VCEL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VCEL
For 52 weeks
30.18 USD
54.1 USD
50 Day MA
48.31 USD
Shares Short Prior Month
3 144 888
200 Day MA
45.02 USD
Short Ratio
10.35
Shares Short
3 390 564
Short Percent
11.01 %
BeatStart